Teva 'Pay-For-Delay Case Will Keep Courts Busy For Years'

 
• By Kevin Grogan

Once again the European Commission has the marketing practices of the pharmaceutical industry in its sights, with Teva the latest company in the spotlight for an alleged 'pay-for-delay' agreement over the sleep disorder drug modafinil.

Woman with magnifying Glass Looking at Files
Teva probe will be deep and lengthy • Source: Shutterstock

More from Legal & IP

More from Business